Please select an option below to help us tailor your newsletter to best suit your content interests!
Our West family is so proud to support the annual Think Pink Memphis luncheon! <br> This weekend, Dr. Jason Porter and Dr. Carmel Verrier participated in the expert panel discussion, sharing information about: Screening guidelines Current treatment and surgical options Importance of physical therapy for pre- and post-surgery Resources available across the Mid-South <br> This… Read more »
Dr. Jason Porter details groundbreaking research for KRAS-mutant NSCLC during a Targeted Oncology Community Case Forum. 🎉 Explore the CodeBreaK 100 and CodeBreaK 200 studies, showing promising results and insights into new treatment strategies. Read more about the accelerated approval of new treatment options, and their impact on patients’ lives. Let’s revolutionize #LungCancer care together!… Read more »
Exciting News in Lung Cancer Treatment Dr. Jason Porter joins Dr. Maya Khalil, Dr. Brian Mitzman, and Dr. Rami Manochakian in discussing the strides made in improving patient outcomes with immunotherapy and targeted therapies for non-small cell lung cancer (NSCLC). The group talks about several new clinical trials demonstrating promising results for high… Read more »
This past weekend, Drs. Bradley Somer, Gregory Vidal, and Jason Porter hosted presentations at the Best of ASCO – Memphis Conference! This Post ASCO review showcased abstracts from highly rated presentations and the latest research in oncology education. Our physicians helped lead several discussions including: Dr. Jason Porter: – “Personalizing Treatment for Adult Patients with… Read more »
Exciting updates in GI Cancers! Dr. Axel Grothey from West Cancer Center shared groundbreaking insights at the Total Health Spring Oncology Review and Renew Conference. He highlighted major advancements in targeted therapies and precision medicine for GI cancers. Here are the key highlights: Gastro-Esophageal Junction (GEJ) Cancers: Dr. Grothey revealed a new biomarker, Claudin 18.2… Read more »
Geriatric Oncology is a strong field of interest for our Radiation Oncologist and Co-Director of Clinical Research, Dr. Noam VanderWalde. In this podcast, he discusses the importance of personalization for older cancer patients alongside Dr Akila Viswanathan (Johns Hopkins Medicine) and Dr Ben Movsas (Henry Ford Cancer Institute – Detroit). Click here to listen!
Here at West, we believe that diversity, equity, and inclusion are critical to reducing cancer disparities. On Friday, March 3, Dr. Gregory Vidal led a workshop called “Conversations for Change” aimed to encourage conversations about prevention, diagnosis, and treatment of cancer to primary care providers in our community. Discussions included: – Diagnostic Standards… Read more »